Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Guna Proboka"'
Autor:
Guna Proboka, Andra Tilgase, Sergejs Isajevs, Tatjana Zablocka, Evija Olmane, Agnija Rasa, Pēteris Alberts
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 424-430 (2020)
Adrenal gland melanoma is an extremely rare diagnosis with less than 20 cases reported. The criteria for diagnosing adrenal gland melanoma include involvement of only one adrenal gland, presence of melanin pigment in the histological examination of t
Externí odkaz:
https://doaj.org/article/4f0c9f7c4f91402092028ac08cd6b7a1
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Melanoma is considered an aggressive malignancy with a tendency of forming metastasis in the brain. Less than 10% of all melanoma cases present with unknown primary tumor location. This diagnose is yet to be fully understood, because there are only t
Externí odkaz:
https://doaj.org/article/64ec4ec18885415ba22906d9cba610a8
Autor:
Sergejs Isajevs, Guna Proboka, Agnija Rasa, Evija Olmane, Pēteris Alberts, Tatjana Zablocka, Andra Tilgase
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 1, Pp 424-430 (2020)
Case Reports in Oncology, Vol 13, Iss 1, Pp 424-430 (2020)
Adrenal gland melanoma is an extremely rare diagnosis with less than 20 cases reported. The criteria for diagnosing adrenal gland melanoma include involvement of only one adrenal gland, presence of melanin pigment in the histological examination of t
Autor:
Guna Proboka, Evija Olmane, Dite Venskus, Māra Romanovska, Zanda Krastiņa, Kārlis Kupčs, Sergejs Isajevs, Romualds Erdmanis, Linda Brokāne, Jurijs Nazarovs, Pēteris Alberts
Publikováno v:
APMIS. 124:896-904
Oncolytic virotherapy is a recent addition to cancer treatment. Here, we describe positive treatment outcomes in three patients using Rigvir virotherapy. One of the patients is diagnosed with melanoma stage IV M1c, one with small cell lung cancer sta
Autor:
Guna Proboka, Ainārs Baginskis, Simona Doniņa, Kristīne Azarjana, Anders Molven, Ingrīda Čēma, Rūta Veinalde, Aija Ozola, Dace Pjanova, Lars A. Akslen
Publikováno v:
Melanoma Research. 23:221-226
Hereditary cutaneous melanoma is associated with mutations in the high-risk CDKN2A gene in about 40% of melanoma-prone families. Mutations in the CDK4 gene are the cause in only a few pedigrees. In this study, we analyzed 20 Latvian familial melanoma
Autor:
Guna Proboka, Simona Doniņa, Ludmila Eņģele, Olita Heisele, Kristīne Azarjana, Baiba Streinerte, Dace Pjanova, Ilona Mandrika, Ingrīda Čēma, Ramona Petrovska, Aija Ozola
Publikováno v:
Cancer Genetics. 206:81-91
To evaluate the association ofmelanocortin 1 receptorgene (MC1R) variants withmelanomarisk in a Latvian population, theMC1Rgene was sequenced in 200 melanoma patients and 200 control persons. A functional study of previously uncharacterized, rareMC1R
Autor:
Pēteris Alberts, Aina Muceniece, Ieva Strēle, Guna Proboka, Dite Venskus, Björn Jonsson, Jurgis Auziņš, Simona Doniņa
Publikováno v:
Melanoma Research
An oncolytic, nonpathogenic ECHO-7 virus adapted for melanoma that has not been genetically modified (Rigvir) is approved and registered for virotherapy, an active and specific immunotherapy, in Latvia since 2004. The present retrospective study was
Autor:
Guna Proboka, Kristīne Azarjana, Aija Ozola, Ingrida Cema, Olita Heisele, Ludmila Engele, Baiba Streinerte, Dace Pjanova, S. Donina
Publikováno v:
Melanoma Research. 21:e40-e41